Sarah Kathryn Rouan

Insider Reports History

Location
Dublin, OH
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah Kathryn Rouan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 4,390 $163,351 $37.21 02 Jan 2026 Direct
NAVIDEA BIOPHARMACEUTICALS, INC. Director Common Stock 18,242 $1,605 $0.0880 30 Jun 2021 Direct
Viking Therapeutics, Inc. Director Stock Option (Right to Buy) 20,400 02 Jan 2026 Direct

Insider Reports Filed by Sarah Kathryn Rouan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VKTX Viking Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 05 Jan 2026, 20:24
VKTX Viking Therapeutics, Inc. 31 Mar 2025 1 +$29,943 4/A Director 08 Apr 2025, 19:05
VKTX Viking Therapeutics, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 20:11
VKTX Viking Therapeutics, Inc. 25 Oct 2024 3 -$836,110 4 Director 25 Oct 2024, 19:28
VKTX Viking Therapeutics, Inc. 08 Feb 2024 3 -$493,250 4 Director 08 Feb 2024, 19:38
VKTX Viking Therapeutics, Inc. 19 Jan 2024 3 -$441,900 4 Director 19 Jan 2024, 20:35
VKTX Viking Therapeutics, Inc. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 21:25
VKTX Viking Therapeutics, Inc. 03 Jan 2023 1 $0 4 Director 04 Jan 2023, 17:11
VKTX Viking Therapeutics, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 18:10
/report/000143774921016598-rouan-sarah-kathryn-2021-06-30 NAVIDEA BIOPHARMACEUTICALS, INC. 30 Jun 2021 1 $0 4 Director 07 Jul 2021, 17:46